Is the NICE process flawed?
Lancet
.
2002 Jun 15;359(9323):2119-20.
doi: 10.1016/S0140-6736(02)08932-8.
Authors
Jim Cassidy
,
John Bridgewater
,
Paul Mainwaring
,
Will Steward
,
Harpreet Wasan
PMID:
12086799
DOI:
10.1016/S0140-6736(02)08932-8
No abstract available
Publication types
Letter
MeSH terms
Antineoplastic Agents / therapeutic use*
Colorectal Neoplasms / drug therapy*
Drug Approval*
Humans
National Health Programs
Randomized Controlled Trials as Topic
United Kingdom
Substances
Antineoplastic Agents